drugset / Trial / NCT01581736

Molecular Regulation of Muscle Glucose Metabolism

NCT01581736

Phase 1 Terminated 48 enrolled Mayo Clinic Arizona State University · collab
NaSingle-groupOpen-labelBasic science

Summary

This protocol is being conducted to determine the mechanisms responsible for insulin resistance, obesity and type 2 diabetes.

Timeline

Start
2012-04
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Protein / enzyme biologic 80 unknown